Ben Neuman

Ben Neuman is a Professor of Biological Sciences at Texas A&M University, affiliated with the College of Arts & Sciences. He holds a B.S. in Biology from the University of Toledo (1997) and a Ph.D. in Animal and Microbial Sciences from the University of Reading, UK (2001). Postdoctoral research at The Scripps Research Institute focused on virology, particularly SARS-CoV-2 and coronavirus biology.

His research interests span virology, antiviral drug development, and innovative detection technologies using nanotechnology. He investigates viral genome architecture, host-pathogen interactions, and SARS-CoV-2 variants in wildlife. Key contributions include work on coronavirus replicative organelles, drug design targeting viral proteases, and novel biosensing methods like luminescence resonance energy transfer.

Recent articles highlight advancements in viral detection tools, genetic innovation in aquatic coronaviruses, and critiques of unproven SARS-CoV-2 origin theories. Neuman’s lab develops thermostable analytical techniques and PROTAC-based antiviral strategies. His work emphasizes biosafety protocols for high-containment pathogens and the role of wildlife in viral spread.